Form 4 Filing for Miralles Gines Diego

Miralles Gines Diego, a director at Contineum Therapeutics, Inc. (CTNM), was granted a stock option for 19,000 shares of Class A Common Stock on June 26, 2026. This option, granted under the company's 2024 Equity Incentive Plan, is part of the Non-Employee Director Compensation Program. The option will vest in full on June 26, 2027, or at the next annual stockholder meeting, provided continuous service is maintained. The exercise price for the option is $14.19 per share, with an expiration date of June 25, 2036. This transaction is reported on Form 4.